Sex Does Not Affect the Performance of Noninvasive Tests for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease
Paula Höfinger(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Lukas Hartl(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Eva Schaden(Medical University of Vienna), Georg Semmler(University of Southern Denmark), L Balcar(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Albert Friedrich Stättermayer(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Christian Sebesta(Medical University of Vienna), Marlene HINTERSTEININGER(Medical University of Vienna), Michael TRAUNER(Medical University of Vienna), Helena Schluchter(Austrian Institute for Health Technology Assessment GmbH), Mattias MANDORFER(Medical University of Vienna), Paul Thöne(Medical University of Vienna)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Twenty-year experience with extracorporeal life support as bridge to lung transplantation
|Journal of Thoracic and Cardiovascular Surgery|2019|131
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130